Levetiracetam Zentiva

Levetiracetam, the active ingredient in Levetiracetam Zentiva, is an anticonvulsant presented as an oral dosage form for oral use. It is prescribed to control various types of epileptic seizures in adults and children. GNH USA supplies Levetiracetam Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that modulates neuronal excitability to prevent seizure activity. - Partial seizures: decreases frequency of focal onset seizures. - Generalized tonic‑clonic seizures: reduces occurrence of bilateral convulsive episodes. - Myoclonic seizures: helps control sudden, brief muscle jerks.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired. - Somnolence: increased sleepiness. - Headache: mild to moderate pain. - Irritability: mood changes or agitation. - Nausea: upset stomach.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Stevens‑Johnson syndrome: rare skin disorder with blistering. - Blood dyscrasias: abnormal blood counts. - Suicidal thoughts: new or worsening depression. - Severe skin rash: widespread redness or peeling. - Depression: persistent low mood.

Before initiating therapy, consider the following safety measures. - Renal impairment: dose adjustment may be required based on kidney function. - Hepatic impairment: monitor liver enzymes and adjust if necessary. - Concomitant CNS depressants: may increase sedation, use caution. - Pregnancy: risk unknown; discuss benefits and risks with a healthcare professional. - Driving or operating machinery: dizziness may impair performance; exercise caution. - Store below 25°C: keep in the original packaging, protect from moisture.

Levetiracetam can interact with several medicines, influencing its effectiveness or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenytoin: can reduce levetiracetam concentration. - Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression, increase drowsiness. - Other antiepileptics: potential for enhanced seizure control or toxicity. - Hormonal contraceptives: possible reduction in contraceptive efficacy.